Gastroenteritis in Pediatric Population of Qatar

Hamad Medical Corporation3,000 enrolled

Overview

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Gastroenteritis

Interventions

Molecular method (PCR)DIAGNOSTIC_TEST

Stool samples are being processed through molecular method (PCR) for children with GE. Epidemiology of acute Gastroenteritis in the pediatric population in Qatar

Eligibility

Sex: ALLMin age: 3 MonthsMax age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever Exclusion Criteria: 1. Cases of vomiting +/- fever only without diarrhea 2. Suspicion of surgical abdomen 3. Bile stained vomitus 4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency 5. Cases of Inflammatory bowel disease 6. Antibiotic associated diarrhea 7. Patients with immune deficiency 8. Patients with chronic diarrhea (\>2 weeks of diarrhea) 9. Patients receiving long term medication for any disease

Locations (1)

Hamad medical corporation

Doha, Qatar

RECRUITING

Outcomes

Primary Outcomes

sources of viral, bacterial and parasitic GE in the country

Prevalence of viral, bacterial and parasitic GE in children \< 14 years of age in Qatar will be identified by molecular method sample processing

Time frame: 4 years

Secondary Outcomes

seasonal variation of GE in qatar determination

seasonal variation of GE in qatar being determined by number of cases reported during each season

Time frame: 4 years

comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine

comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine by detection of source of GE in vaccinated children by molecular method.

Time frame: 4 years

Central Contacts

Dr.Khalid Alansari

CONTACT

+974 55336166 kalansari1@hamad.qa

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.